ProJenX partners with Unlearn to use AI-generated digital twins in ALS trial
The partnership will employ the ALS-Digital Twin Generator of Unlearn to enhance the trial's evaluation process.
Pharmabiz1h
WHO releases guidance to improve the design, conduct and oversight of clinical trials
WHO releases guidance to improve the design, conduct and oversight of clinical trials: Geneva Friday, September 27, 2024, 14:00 Hrs [IST] The World Health Organization (WHO) relea ...
Anbogen Therapeutics: Anbogen Announces Drug Supply Collaboration with BeiGene to Evaluate Combination Therapy in Colorectal Cancer
Anbogen, a clinical-stage biotech company, today announced a drug supply collaboration to evaluate the combination of Anbogen's HDAC inhibitor, ABT-301 ...
Anbogen Announces Drug Supply Collaboration with BeiGene to Evaluate Combination Therapy in Colorectal Cancer
Anbogen, a clinical-stage biotech company, today announced a drug supply collaboration to evaluate the combination of Anbogen's HDAC inhibitor, ABT-301, with BeiGene's anti-PD-1 antibody tislelizumab, ...
News Medical6h
Review highlights evolving role of endovascular therapy in treating ischemic stroke
Stroke related to large vessel occlusion (LVO) is a leading cause of disability and death worldwide. Endovascular therapy (minimally invasive procedures like catheterization done inside the blood ...
BLACK ENTERPRISE Empowers Black Men: Prostate Cancer In The Black Community And The Importance Of Clinical Trials
Prostate cancer disproportionately affects Black men, leading to higher mortality rates and worse health outcomes compared to ...
clinicaltrialsarena9h
ProJenX and Unlearn partner to use AI-generated digital twins in ALS trial
ProJenX and Unlearn partnered to implement genAI technology for a Phase I trial of prosetin for amyotrophic lateral sclerosis ...
Alzheimer’s Drug Developer Cassava Paying $40 Million to Settle Doctored Data Claims
The Securities and Exchange Commission alleged that a researcher for the company manipulated trial data to make its drug ...
Stocks to Watch: Cassava Sciences, Scholastic, MeridianLink
MeridianLink announced an underwritten secondary public offering of 6 million shares by funds managed by Thoma Bravo. The selling stockholders plan to grant the underwriter an option to purchase up to ...
SEC Charges Cassava Sciences, Two Former Executives for Misleading Claims About Alzheimer’s Clinical Trial
The Securities and Exchange Commission today announced Cassava Sciences, Inc., its founder and former CEO, Remi Barbier, and its former Senior Vice President of Neuroscience, Dr. Lindsay Burns, will ...
SEC Charges Cassava Sciences, Former Executives for Misleading Claims in Alzheimer's Trial
Cassava Sciences and two former executives will pay more than $40 million to settle charges related to misleading statements made about a clinical trial for the company's purported therapeutic ...
Cassava Sciences settles SEC charges of 'misleading' Alzheimer's trial claims
Relatedly, the SEC also charged Hoau-Yan Wang, a Cassava consultant and an associate professor at the City University of New York's Medical School, for manipulating the reported clinical trial results ...